Kuros Biosciences AG
General ticker "CSBTF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $802.5M (TTM average)
Kuros Biosciences AG follows the US Stock Market performance with the rate: 33.6%.
Estimated limits based on current volatility of 0.6%: low 27.84$, high 28.16$
Short-term CSBTF quotes
Long-term CSBTF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CHF33.56MM | CHF75.56MM | CHF121.36MM |
| Operating Expenses | CHF46.76MM | CHF80.55MM | CHF114.03MM |
| Operating Income | CHF-13.19MM | CHF-5.00MM | CHF7.33MM |
| Non-Operating Income | CHF3.42MM | CHF1.65MM | CHF-3.16MM |
| Interest Expense | CHF1.75MM | CHF0.15MM | CHF0.30MM |
| R&D Expense | CHF5.60MM | CHF6.98MM | CHF8.87MM |
| Income(Loss) | CHF-9.78MM | CHF-3.35MM | CHF4.17MM |
| Taxes | CHF0.38MM | CHF0.37MM | CHF2.12MM |
| Profit(Loss)* | CHF-13.73MM | CHF-3.51MM | CHF2.12MM |
| Stockholders Equity | CHF56.71MM | CHF58.75MM | CHF66.96MM |
| Inventory | CHF4.86MM | CHF9.44MM | CHF16.93MM |
| Assets | CHF71.46MM | CHF84.54MM | CHF107.26MM |
| Operating Cash Flow | CHF-8.84MM | CHF3.14MM | CHF-0.38MM |
| Capital expenditure | CHF0.33MM | CHF1.11MM | CHF2.03MM |
| Investing Cash Flow | CHF-0.33MM | CHF-1.11MM | CHF-2.03MM |
| Financing Cash Flow | CHF-0.17MM | CHF1.34MM | CHF1.17MM |
| Earnings Per Share** | CHF-0.38 | CHF-0.09 | CHF0.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.